| 1 | Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma. 2021;13:3220 doi: 10.3390/cancers13133220 |
| 2 | Vulture Genomes Reveal Molecular Adaptations Underlying Obligate Scavenging and Low Levels of Genetic Diversity. 2021;38:3649 doi: 10.1093/molbev/msab130 |
| 3 | Farnesoid X receptor induces cell death and sensitizes to TRAIL-induced inhibition of growth in colorectal cancer cells through the up-regulation of death receptor 5. 2019;519:824 doi: 10.1016/j.bbrc.2019.09.033 |
| 4 | Folic acid conjugated Prussian blue nanoparticles: Synthesis, physicochemical characterization and targeted cancer cell sensing. 2020;187:110655 doi: 10.1016/j.colsurfb.2019.110655 |
| 5 | Changes of serum metabolites levels during neoadjuvant chemoradiation and prediction of the pathological response in locally advanced rectal cancer. 2022;18: doi: 10.1007/s11306-022-01959-8 |
| 6 | A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment. 2020;9:3529 doi: 10.3390/jcm9113529 |
| 7 | Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma—An Unexpected Correlation to Guide Future Treatment?. 2023;24:8198 doi: 10.3390/ijms24098198 |
| 8 | Acetylcholine receptors: Key players in cancer development. 2019;31:46 doi: 10.1016/j.suronc.2019.09.003 |
Journal of Cancer Metastasis and Treatment
